Genetic Association of Epilepsy and Anti-Epileptic Drugs Treatment in Jordanian Patients.
Laith Naser Al-EitanIslam M Al-DalalaAfrah K ElshammariWael H KhreisatAseel F NimiriAdan H AlnaamnehHanan A AljamalMansour Abdullah AlghamdiPublished in: Pharmacogenomics and personalized medicine (2020)
Our findings suggested that SLC1A1, FAM131B, and GPLD1 polymorphisms increasing the risk of generating epilepsy, while FAM131B, GABRA1, and CACNG5 variants may play a role in predicting drug response in patients with epilepsy (PWE).